Skip to content

Research on Physicians' Clinical Practice for Generalized Anxiety Disorder (GAD)

Research on Physicians' Clinical Practice for Generalized Anxiety Disorder (GAD) - Research on Physicians' Clinical Practice for Generalized Anxiety Disorder (GAD)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000049572
Enrollment
500
Registered
2022-11-21
Start date
2022-12-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized anxiety disorder

Interventions

None listed

Sponsors

Viatris Pharmaceuticals Japan Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Respondents must agree to participate in the research. 2.Respondents must be specializing in psychiatry or psychosomatic medicine. 3.Respondents must have seen 10 or more outpatients in the most recent one month.

Exclusion criteria

Exclusion criteria: There are no exclusion criteria for this study.

Design outcomes

Primary

MeasureTime frame
Recognition/awareness of GAD Facts and issues related to diagnosis and treatment of GAD

Countries

Japan

Contacts

Public ContactHaruhiko Seki

INTAGE Healthcare Marketing Insight Division Healthcare Research Department 1

haruhiko.seki@intage.com03-5295-1579

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026